Skip to main content

Drugs (Surveillance)

Volume 22: debated on Thursday 29 April 1982

The text on this page has been created from Hansard archive content, it may contain typographical errors.

asked the Secretary of State for Social Services if he will introduce measures to increase the influence of the patient on the committee that monitors developments in drugs and medications by having representatives of community health councils as members of this surveillance body.

No. Members of the Committee on Safety of Medicines are appointed for the professional expertise they bring to the subject and not as representatives of particular interests.